References
- Abildgaard U. Acceleration of fibrin polymerization by acetate and other low molecular ions. Scand. J. clin. Lab. Invest 1964; 16: 521
- Edsall J. T., Lever W. F. Effects of ions and neutral molecules on fibrin clotting. J. biol. Chem 1951; 191: 735
- Ehrenpreis S., Sheraga H. A. Observations on the analysis for thrombin and the inactivation of fibrin monomer. Ibid 1957; 227: 1040
- Ehrenpreis S., Sheraga H. A., Laskowski M., Jr, Donnelly T. H., Scheraga H. A. Equilibria in the fibrinogen-fibrin conversion. IV. Kinetics of the conversion of fibrinogen to fibrin monomer. J. Amer. chem. Soc 1958; 80: 4255
- Ferry J. D., Morrison P. R. Preparation and properties of serum and plasma proteins. VIII. The conversion of human fibrinogen to fibrin under various conditions. Ibid 1947; 69: 388
- Godal H. C. Precipitation of human fibrinogen with heparin. Scand. J. clin. Lab. Invest 1960; 12: 56
- Godal H. C., Abildgaard U. The symptomatic effect of anticoagulant therapy in defibrination syndrome associated with demonstrable fibrin in plasma. Acta med. scand 1963; 174: 311
- Koppel J. L., Mueller Houg D., Olwin J. H. Possible relation of a plasma enzyme activity to thromboembolism. Surg. Gynec. Obstet 1961; 112: 315
- Markwardt F., Walsman P. Untersuchungen über den Mechanismus der Antithrombinwirkung des Heparins. Hoppe-Seylers Z. physiol. Chem 1959; 317: 64
- Shainoff J. D., Page I. Significance of cryoprofibrin in fibrinogen-fibrin conversion. J. exp. Med 1962; 116: 687
- Triantaphyllopoulos D. C. Anticoagulant action of TAME and AFIF. Amer. J. Physiol 1961; 200: 771